Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
Adams, S., Schmid, P., Rugo, H.S., Winer, E.P., Loirat, D., Awada, A., Cescon, D.W., Iwata, H., Campone, M., Nanda, R., Hui, R., Curigliano, G., Toppmeyer, D., O’Shaughnessy, J., Loi, S., Paluch-Shimon, S., Tan, A.R., Card, D., Zhao, J., Karantza, V., Cortés, J.
Published in Annals of oncology (01.03.2019)
Published in Annals of oncology (01.03.2019)
Get full text
Journal Article
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1
André, F., Ciruelos, E.M., Juric, D., Loibl, S., Campone, M., Mayer, I.A., Rubovszky, G., Yamashita, T., Kaufman, B., Lu, Y.-S., Inoue, K., Pápai, Z., Takahashi, M., Ghaznawi, F., Mills, D., Kaper, M., Miller, M., Conte, P.F., Iwata, H., Rugo, H.S.
Published in Annals of oncology (01.02.2021)
Published in Annals of oncology (01.02.2021)
Get full text
Journal Article
Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
Adams, S., Loi, S., Toppmeyer, D., Cescon, D.W., De Laurentiis, M., Nanda, R., Winer, E.P., Mukai, H., Tamura, K., Armstrong, A., Liu, M.C., Iwata, H., Ryvo, L., Wimberger, P., Rugo, H.S., Tan, A.R., Jia, L., Ding, Y., Karantza, V., Schmid, P.
Published in Annals of oncology (01.03.2019)
Published in Annals of oncology (01.03.2019)
Get full text
Journal Article
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
Cardoso, F, Senkus, E, Costa, A, Papadopoulos, E, Aapro, M, André, F, Harbeck, N, Aguilar Lopez, B, Barrios, C H, Bergh, J, Biganzoli, L, Boers-Doets, C B, Cardoso, M J, Carey, L A, Cortés, J, Curigliano, G, Diéras, V, El Saghir, N S, Eniu, A, Fallowfield, L, Francis, P A, Gelmon, K, Johnston, S R D, Kaufman, B, Koppikar, S, Krop, I E, Mayer, M, Nakigudde, G, Offersen, B V, Ohno, S, Pagani, O, Paluch-Shimon, S, Penault-Llorca, F, Prat, A, Rugo, H S, Sledge, G W, Spence, D, Thomssen, C, Vorobiof, D A, Xu, B, Norton, L, Winer, E P
Published in Annals of oncology (01.08.2018)
Published in Annals of oncology (01.08.2018)
Get full text
Journal Article
Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial
Rugo, H.S., Diéras, V., Gelmon, K.A., Finn, R.S., Slamon, D.J., Martin, M., Neven, P., Shparyk, Y., Mori, A., Lu, D.R., Bhattacharyya, H., Bartlett, C.H.u.a.n.g., Iyer, S., Johnston, S., Ettl, J., Harbeck, N.
Published in Annals of oncology (01.04.2018)
Published in Annals of oncology (01.04.2018)
Get full text
Journal Article
Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
Rugo, H.S., Bianchini, G., Cortes, J., Henning, J.-W., Untch, M.
Published in ESMO open (01.08.2022)
Published in ESMO open (01.08.2022)
Get full text
Journal Article
A phase Ib study of pexidartinib (PLX3397) and weekly paclitaxel in patients with advanced solid tumors including an ovarian cancer subset
Wesolowski, R, Sharma, N, West, B, Coussens, L, Marimuthu, A, Pelayo, M, Le, M.H, Hsu, H, Karlin, D.A, Rugo, H.S
Published in Gynecologic oncology (01.06.2016)
Published in Gynecologic oncology (01.06.2016)
Get full text
Journal Article
Relationship between tumor infiltrating lymphocyte (TIL) levels and response to pembrolizumab (pembro) in metastatic triple-negative breast cancer (mTNBC): Results from KEYNOTE-086
Loi, S., Adams, S., Schmid, P., Cortés, J., Cescon, D.W., Winer, E.P., Toppmeyer, D.L., Rugo, H.S., De Laurentiis, M., Nanda, R., Iwata, H., Awada, A., Tan, A., Wang, A., Aktan, G., Karantza, V., Salgado, R.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Alpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial
André, F., Ciruelos, E.M., Rubovszky, G., Campone, M., Loibl, S., Rugo, H.S., Iwata, H., Conte, P., Mayer, I.A., Kaufman, B., Yamashita, T., Lu, Y.-S., Inoue, K., Takahashi, M., Pápai, Z., Longin, A.-S., Mills, D., Wilke, C., Hirawat, S., Juric, D.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
5026 POSTER DISCUSSION Sorafenib (SOR) Plus Chemotherapy (CRx) for Treatment (tx) of Patients (pts) With HER2-negative Locally Advanced (adv) or Metastatic (met) Breast Cancer (BC) and Prior Bevacizumab (BEV): Subgroup Analysis of AC01B07
Hudis, C.A, Hermann, R.C, Makari-Judson, G, Isaacs, C, Beck, J.T, Kaklamani, V.G, Rugo, H.S, Wang, W, Li, S, Schwartzberg, L.S
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
269P Patient-reported outcomes (PRO) with talazoparib (TALA) vs physician’s choice chemotherapy (PCT) in patients (pts) with HER2- advanced breast cancer (ABC) and a germline BRCA1/2 mutation (gBRCAm): Subgroup analysis of pts with and without TALA dose reductions vs PCT in the EMBRACA trial
Rugo, H.S., Niyazov, A., Bhattacharyya, H., Arondekar, B., Hurvitz, S.A.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
Gennari, A., André, F., Barrios, C.H., Cortés, J., de Azambuja, E., DeMichele, A., Dent, R., Fenlon, D., Gligorov, J., Hurvitz, S.A., Im, S.-A., Krug, D., Kunz, W.G., Loi, S., Penault-Llorca, F., Ricke, J., Robson, M., Rugo, H.S., Saura, C., Schmid, P., Singer, C.F., Spanic, T., Tolaney, S.M., Turner, N.C., Curigliano, G., Loibl, S., Paluch-Shimon, S., Harbeck, N.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Modi, Shanu, Jacot, William, Yamashita, Toshinari, Sohn, Joohyuk, Vidal, Maria, Tokunaga, Eriko, Tsurutani, Junji, Ueno, Naoto T., Prat, Aleix, Chae, Yee Soo, Lee, Keun Seok, Niikura, Naoki, Park, Yeon Hee, Xu, Binghe, Wang, Xiaojia, Gil-Gil, Miguel, Li, Wei, Pierga, Jean-Yves, Im, Seock-Ah, Moore, Halle C.F., Rugo, Hope S., Yerushalmi, Rinat, Zagouri, Flora, Gombos, Andrea, Kim, Sung-Bae, Liu, Qiang, Luo, Ting, Saura, Cristina, Schmid, Peter, Sun, Tao, Gambhire, Dhiraj, Yung, Lotus, Wang, Yibin, Singh, Jasmeet, Vitazka, Patrik, Meinhardt, Gerold, Harbeck, Nadia, Cameron, David A.
Published in The New England journal of medicine (07.07.2022)
Published in The New England journal of medicine (07.07.2022)
Get full text
Journal Article
First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis
Emens, L.A., Adams, S., Barrios, C.H., Diéras, V., Iwata, H., Loi, S., Rugo, H.S., Schneeweiss, A., Winer, E.P., Patel, S., Henschel, V., Swat, A., Kaul, M., Molinero, L., Patel, S., Chui, S.Y., Schmid, P.
Published in Annals of oncology (01.08.2021)
Published in Annals of oncology (01.08.2021)
Get full text
Journal Article
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
Cardoso, F., Paluch-Shimon, S., Senkus, E., Curigliano, G., Aapro, M.S., André, F., Barrios, C.H., Bergh, J., Bhattacharyya, G.S., Biganzoli, L., Boyle, F., Cardoso, M.-J., Carey, L.A., Cortés, J., El Saghir, N.S., Elzayat, M., Eniu, A., Fallowfield, L., Francis, P.A., Gelmon, K., Gligorov, J., Haidinger, R., Harbeck, N., Hu, X., Kaufman, B., Kaur, R., Kiely, B.E., Kim, S.-B., Lin, N.U., Mertz, S.A., Neciosup, S., Offersen, B.V., Ohno, S., Pagani, O., Prat, A., Penault-Llorca, F., Rugo, H.S., Sledge, G.W., Thomssen, C., Vorobiof, D.A., Wiseman, T., Xu, B., Norton, L., Costa, A., Winer, E.P.
Published in Annals of oncology (01.12.2020)
Published in Annals of oncology (01.12.2020)
Get full text
Journal Article